References
- Hess A. D., Bright E. G. Cyclosporin inhibits T-cell activation at two distinct levels: role of the CD28 activation pathway. Transplant Proc. 1991; 23: 961–966
- Granelli-Piperno A. In situ hybridisation for interleukin 2 receptor mRNA in T-cells activated in the presence or absence of cyclosporin A. J. Exp. Med. 1988; 5: 1649–1658
- Nussenblatt R. B., Palestine A. G., Chan C. C. Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am. J. Ophthalmol. 1983; 96: 275–282
- Towler H. M., Cliffe A. M., Whiting P. H., Forrester J. V. Low dose cyclosporin A therapy in chronic posterior uveitis. Eye 1989; 3: 282–287
- Towler H. M., Whiting P. H., Forrester J. V. Combination of low dose Cyclosporin A and steroid therapy in chronic intraocular inflammation. Eye 1990; 4: 514–520
- Klintmalm G., Sawe J., Ringden O., Von Bahr C., Magnusson A. Cyclosporin plasma levels in renal transplant patients. Association with renal toxicity and allograft rejection. Transplantation 1985; 39: 132–137
- Whiting P. H., Towler H. M.A., Cliffe A. M., Forrester J. V. The use of lithium clearance measurements to assess renal tubular function in cyclosporin treated uveitis patients. Lithium 1990; 1: 245–250
- Klintmalm G., Bohman S., Sundelin B., Wilczek H. Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: Beneficial effect of low doses in early post transplant period. Lancet 1984; ii: 950–954
- Propper D. J., Whiting P. H., Power D. A., Edward N., Catto G. R. The effects of nifedipine on graft function in renal allograft recipients treated with cyclosporin A. Clin Nephrol. 1989; 32: 62–67
- Dieperink H., Leysasac P. P., Kemp E., Steinbruckl D., Starklint H. Glomerulotubular function in cyclosporin A treated rats. Clin. Nephrol. 1986; 25(suppl)578–582
- Whiting P. H., Thomson A. W. Pathological affects of cyclosporin A in experimental models. Cyclosporin: Mode of Action and Clinical Application, A. W. Thompson. Kluwer Academic publishers, LancasterUK 1989; 303–323
- McNally P. G., Walls J., Feehally J. The effect of nifedipine on renal function in normotensive cyclosporine A treated renal allograft patients. Nephrol. Dial. Transplant. 1990; 5: 962–968
- Levey A. S., Perrone R. D., Madias N. E. Serum creatinine and renal function. Ann. Rev. Med. 1988; 22: 465
- Hagstram K. E., Nordefelt I., Svensson L. Comparison of different methods for determination of glomerular filtration rate in renal disease. Scan. J. Clin. Lab. Invest. 1974; 34: 31–36
- Whiting P. H., Propper D. J., Simpson J. G., McKay J., Jones M. C., Catto G. R.D. The use of lithium clearance measurements to assess renal tubular function in experimental and clinical cyclosporin nephrotoxicity. Transplant Proc. 1988; 20(suppl 3)845–849
- Vincent H. H., Wenting G. J., Schalekamp M. A., Jeekel J., Weimar W. Impaired fractional excretion of lithium: a very early marker of cyclosporin nephrotoxicity. Transplant Proc. 1987; 19: 4147–4148
- Mobb G. E., Veitch P. S., Bell P. R.F. Are serum creatinine levels adequate to identify the onset of chronic cyclosporin A nephrotoxicity. Transplant Proc. 1990; 22: 1708–1710
- Deray G., Lehoang P., Cacoub P., Aupetit B., Mertani A., Martinez F., Rottenbourg J. Renal function and blood patients in patients treated with cyclosporin A for uveitis. Eur. J. Clin. Pharmacol. 1988; 34: 601–604
- Workshop of the research unit of the Royal College of Physicians of London; Dept. of Dermatology, University of Glasgow; British Association of Dermatologists Guidelines for management of psoriasis. Br. Med. J. 1991; 303: 829–835
- McNally P. G., Walls J., Feehally J. The effect of nifedipine on renal function in normrtensive Cyclosporine-A-treated renal allograft patients. Nephrol. Dial. Transplant. 1990; 5: 962–968